Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,198 | 5,620 | 9,790 | 12,360 | 24,254 |
| Marketable Securities | 22,336 | 21,356 | 17,912 | 17,327 | 7,410 |
| Receivables | 334 | 256 | 147 | 46 | N/A |
| TOTAL | $26,400 | $27,410 | $28,105 | $30,200 | $32,340 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 178 | 189 | 201 | 212 | 223 |
| TOTAL | $178 | $189 | $201 | $212 | $223 |
| Total Assets | $26,578 | $27,599 | $28,306 | $30,412 | $32,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 94 | 195 | 110 | 265 | 227 |
| Accrued Expenses | 1,712 | 1,293 | 1,075 | 1,726 | 1,198 |
| TOTAL | $1,857 | $1,537 | $1,232 | $2,037 | $1,469 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 173 | 168 | 194 | 228 | 216 |
| TOTAL | $136 | $149 | $162 | $175 | $187 |
| Total Liabilities | $1,993 | $1,686 | $1,394 | $2,212 | $1,656 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,070 | 30,976 | 30,925 | 30,921 | 30,662 |
| Common Shares | 310 | 310 | 309 | 309 | 307 |
| Retained earnings | -225,506 | -222,995 | -220,707 | -218,385 | -214,909 |
| Other shareholders' equity | -935 | -898 | -879 | -847 | -794 |
| TOTAL | $24,585 | $25,913 | $26,912 | $28,200 | $30,907 |
| Total Liabilities And Equity | $26,578 | $27,599 | $28,306 | $30,412 | $32,563 |